Literature DB >> 19409936

Peripheral mechanisms in the control of appetite and related experimental therapies in obesity.

Michael Camilleri1.   

Abstract

The function of the stomach and the gut hormonal responses to food ingestion constitute highly integrated homeostatic responses that maintain euglycemia and normal digestion. This intrinsic feedback involves vagal and hormonal mechanisms. Important signals such as GLP-1 and PYY that arise peripherally induce satiation and also delay gastric emptying or increase insulin secretion. Novel therapies are being developed to mimic or enhance these feedback mechanisms and to control appetite as a means to treat obesity.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19409936      PMCID： PMC3898935          DOI： 10.1016/j.regpep.2009.04.011

Source DB:  PubMed          Journal:  Regul Pept        ISSN： 0167-0115


  37 in total

Review 1.  Obesity.

Authors:  Susan Z Yanovski; Jack A Yanovski
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

2.  Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.

Authors:  Marco Landi; Tiziano Croci; Murielle Rinaldi-Carmona; Jean-Pierre Maffrand; Gérard Le Fur; Luciano Manara
Journal:  Eur J Pharmacol       Date:  2002-08-16       Impact factor: 4.432

3.  Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans.

Authors:  Silvia Delgado-Aros; Doe-Young Kim; Duane D Burton; George M Thomforde; Debra Stephens; Benjamin H Brinkmann; Adrian Vella; Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-03       Impact factor: 4.052

4.  Vagotomy for treatment of severe obesity.

Authors:  J G Kral
Journal:  Lancet       Date:  1978-02-11       Impact factor: 79.321

5.  Is there a role for gastric accommodation and satiety in asymptomatic obese people?

Authors:  D Y Kim; M Camilleri; J A Murray; D A Stephens; J A Levine; D D Burton
Journal:  Obes Res       Date:  2001-11

6.  Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans.

Authors:  J Schirra; U Wank; R Arnold; B Göke; M Katschinski
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

7.  Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device.

Authors:  Michael Camilleri; James Toouli; Miguel F Herrera; Lilian Kow; Juan Pablo Pantoja; Charles J Billington; Katherine S Tweden; Richard R Wilson; Frank G Moody
Journal:  Surg Obes Relat Dis       Date:  2008-09-12       Impact factor: 4.734

8.  Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction.

Authors:  S Delgado-Aros; A Vella; M Camilleri; P A Low; D D Burton; G M Thomforde; D Stephens
Journal:  Neurogastroenterol Motil       Date:  2003-08       Impact factor: 3.598

9.  Gastric capacity, test meal intake, and appetitive hormones in binge eating disorder.

Authors:  Allan Geliebter; Eric K Yahav; Marci E Gluck; Sami A Hashim
Journal:  Physiol Behav       Date:  2004-07

10.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245
View more
  9 in total

Review 1.  Acute exercise and gastric emptying: a meta-analysis and implications for appetite control.

Authors:  Katy M Horner; Matthew M Schubert; Ben Desbrow; Nuala M Byrne; Neil A King
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

2.  Differential effect of glucose ingestion on the neural processing of food stimuli in lean and overweight adults.

Authors:  Martin Heni; Stephanie Kullmann; Caroline Ketterer; Martina Guthoff; Margarete Bayer; Harald Staiger; Fausto Machicao; Hans-Ulrich Häring; Hubert Preissl; Ralf Veit; Andreas Fritsche
Journal:  Hum Brain Mapp       Date:  2013-01-10       Impact factor: 5.038

3.  Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse.

Authors:  Donna M Daly; Sung Jin Park; William C Valinsky; Michael J Beyak
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

Review 4.  Gastrointestinal morbidity in obesity.

Authors:  Andres Acosta; Michael Camilleri
Journal:  Ann N Y Acad Sci       Date:  2014-03-06       Impact factor: 5.691

5.  Effect of high fat-diet and obesity on gastrointestinal motility.

Authors:  Mazen Al Mushref; Shanthi Srinivasan
Journal:  Ann Transl Med       Date:  2013-07-01

6.  Differences in brain responses between lean and obese women to a sweetened drink.

Authors:  L Connolly; K Coveleskie; L A Kilpatrick; J S Labus; B Ebrat; J Stains; Z Jiang; K Tillisch; H E Raybould; E A Mayer
Journal:  Neurogastroenterol Motil       Date:  2013-04-09       Impact factor: 3.598

Review 7.  GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.

Authors:  Dongdong Wang; Emily A Day; Logan K Townsend; Djordje Djordjevic; Sebastian Beck Jørgensen; Gregory R Steinberg
Journal:  Nat Rev Endocrinol       Date:  2021-08-11       Impact factor: 43.330

8.  Correlations of circulating peptide YY and ghrelin with body weight, rate of weight gain, and time required to achieve the recommended daily intake in preterm infants.

Authors:  XiaFang Chen; XueLiang Du; JianXing Zhu; LiJuan Xie; YongJun Zhang; ZhenJuan He
Journal:  Braz J Med Biol Res       Date:  2012-04-26       Impact factor: 2.590

9.  Gastric electrical stimulation for the treatment of obesity: from entrainment to bezoars-a functional review.

Authors:  Martin P Mintchev
Journal:  ISRN Gastroenterol       Date:  2013-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.